Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., April 01, 2024 -- Biomea Fusion, Inc. , a clinical stage biopharmaceutical company focused on the discovery and development of covalent small molecules to treat patients with...

Related Keywords

,Facebook ,Linkedin ,Biomea Fusion Inc ,Twitter ,Nasdaq ,Equity Plan ,Nasdaq Listing Rule ,